202 related articles for article (PubMed ID: 26308522)
1. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis.
Tripathi S; Wang G; White M; Rynkiewicz M; Seaton B; Hartshorn K
PLoS One; 2015; 10(8):e0133454. PubMed ID: 26308522
[TBL] [Abstract][Full Text] [Related]
2. LL-37 modulates human neutrophil responses to influenza A virus.
Tripathi S; Verma A; Kim EJ; White MR; Hartshorn KL
J Leukoc Biol; 2014 Nov; 96(5):931-8. PubMed ID: 25082153
[TBL] [Abstract][Full Text] [Related]
3. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
Nagaoka I; Tamura H; Hirata M
J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
[TBL] [Abstract][Full Text] [Related]
5. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors.
Tjabringa GS; Ninaber DK; Drijfhout JW; Rabe KF; Hiemstra PS
Int Arch Allergy Immunol; 2006; 140(2):103-12. PubMed ID: 16557028
[TBL] [Abstract][Full Text] [Related]
6. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins.
Tripathi S; Tecle T; Verma A; Crouch E; White M; Hartshorn KL
J Gen Virol; 2013 Jan; 94(Pt 1):40-49. PubMed ID: 23052388
[TBL] [Abstract][Full Text] [Related]
7. LL-37 inhibits serum amyloid A-induced IL-8 production in human neutrophils.
Lee HY; Kim SD; Shim JW; Lee SY; Yun J; Bae YS
Exp Mol Med; 2009 May; 41(5):325-33. PubMed ID: 19307752
[TBL] [Abstract][Full Text] [Related]
8. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.
De Yang ; Chen Q; Schmidt AP; Anderson GM; Wang JM; Wooters J; Oppenheim JJ; Chertov O
J Exp Med; 2000 Oct; 192(7):1069-74. PubMed ID: 11015447
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin.
Zhang Z; Cherryholmes G; Shively JE
J Leukoc Biol; 2008 Sep; 84(3):780-8. PubMed ID: 18524973
[TBL] [Abstract][Full Text] [Related]
11. 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,7-dimethoxy-4H-chromen-4-one (MSF-2) suppresses fMLP-mediated respiratory burst in human neutrophils by inhibiting phosphatidylinositol 3-kinase activity.
Liao CH; Chen JJ; Lin JE; Liu CH; Tseng CP; Day YJ
J Cell Physiol; 2011 Jun; 226(6):1519-30. PubMed ID: 20945388
[TBL] [Abstract][Full Text] [Related]
12. Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function.
Lee RM; White MR; Hartshorn KL
Scand J Immunol; 2006 Feb; 63(2):81-9. PubMed ID: 16476006
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
[TBL] [Abstract][Full Text] [Related]
14. Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.
Yanagisawa T; Ishii M; Takahashi M; Fujishima K; Nishimura M
Mol Biol Rep; 2020 Sep; 47(9):6841-6854. PubMed ID: 32886325
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.
Agier J; Brzezińska-Błaszczyk E; Żelechowska P; Wiktorska M; Pietrzak J; Różalska S
J Immunol Res; 2018; 2018():7357162. PubMed ID: 29670923
[TBL] [Abstract][Full Text] [Related]
16. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
17. LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.
Yu Y; Zhang Y; Zhang Y; Lai Y; Chen W; Xiao Z; Zhang W; Jin M; Yu B
Int Immunopharmacol; 2017 Aug; 49():6-12. PubMed ID: 28549244
[TBL] [Abstract][Full Text] [Related]
18. The neuropeptide pituitary adenylate cyclase activating polypeptide modulates Ca2+ and pro-inflammatory functions in human monocytes through the G protein-coupled receptors VPAC-1 and formyl peptide receptor-like 1.
El Zein N; Badran B; Sariban E
Cell Calcium; 2008 Mar; 43(3):270-84. PubMed ID: 17651798
[TBL] [Abstract][Full Text] [Related]
19. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
[TBL] [Abstract][Full Text] [Related]
20. LL37/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy.
Lou X; Chen H; Chen S; Ji H; He T; Chen H; Zhu R; Le Y; Sang A; Yu Y
FASEB J; 2024 Jun; 38(11):e23697. PubMed ID: 38842874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
